ICandida lipolytica/I Bloodstream Infection in an Adult Patient with COVID-19 and Alcohol Use Disorder: A Unique Case and a Systematic Review of the Literature

• Published in: Antibiotics (Basel) 2023-04, Vol.12 (4)
• Main Authors: Simonetti, Omar, Zerbato, Verena, Sincovich, Sara, Cosimi, Lavinia, Zorat, Francesca, Costantino, Venera, Di Santolo, Manuela, Busetti, Marina, Di Bella, Stefano, Principe, Luigi, Luzzati, Roberto
• Format: Article
• Language: English
• Subjects: Alcoholism; Blood; Caspofungin; Drinking of alcoholic beverages; Endocarditis; Fluconazole; Health aspects; Infection; Medical examination
• ISSN: 2079-6382; 2079-6382
• DOI: 10.3390/antibiotics12040691

Candida lipolytica is an uncommon Candida species causing invasive fungemia. This yeast is mainly associated with the colonisation of intravascular catheters, complicated intra-abdominal infections, and infections in the paediatric population. Here, we report a case of C. lipolytica bloodstream infection in a 53-year-old man. He was admitted for an alcohol withdrawal syndrome and mild COVID-19. Among the primary risk factors for candidemia, only the use of broad-spectrum antimicrobials was reported. The empiric treatment was commenced with caspofungin and then targeted with intravenous fluconazole. Infective endocarditis was ruled out using echocardiography, and PET/TC was negative for other deep-seated foci of fungal infection. The patient was discharged after blood culture clearance and clinical healing. To the best of our knowledge, this is the first case of C. lipolytica candidemia in a patient with COVID-19 and alcohol use disorder. We performed a systematic review of bloodstream infections caused by C. lipolytica. Clinicians should be aware of the possibility of C. lipolytica bloodstream infections in patients with alcohol use disorder, especially in a COVID-19 setting.